{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:23Z","timestamp":1760060063008,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Peritoneal dissemination in colorectal cancer (CRC) is associated with poor prognosis due to limited efficacy of current therapeutic strategies. The cholinergic receptor nicotinic beta 2 subunit (CHRNB2), a component of the acetylcholine receptor, has been implicated in other malignancies, but its role in CRC remains unknown. Methods: This study evaluated the expression and function of CHRNB2 in CRC. CHRNB2 mRNA levels were quantified by qRT-PCR in cell lines and clinical specimens. Functional assays were conducted using CRC cell lines with high CHRNB2 expression, in which CHRNB2 was knocked down by shRNA. Cell proliferation, migration, and invasion were assessed in vitro. In vivo effects were evaluated using subcutaneous and peritoneal xenograft models. The impact of CHRNB2 monoclonal antibody (mAb) treatment on CRC cell proliferation was also examined. Clinical correlations were assessed between CHRNB2 expression and clinicopathological features, including recurrence patterns. Results: CHRNB2 expression varied among CRC cell lines, with the highest levels observed in LOVO cells. CHRNB2 knockdown significantly inhibited proliferation, migration, and invasion in vitro and suppressed tumor growth in vivo. CHRNB2 mAb treatment reduced cell proliferation. Clinically, high CHRNB2 expression correlated with a significantly higher cumulative rate of peritoneal recurrence, but not with recurrence in the liver, lungs, or lymph nodes. Multivariate analysis identified high CHRNB2 expression and T4 tumor depth as independent predictors of peritoneal recurrence. Conclusions: CHRNB2 promotes the malignant phenotype of CRC, particularly in peritoneal dissemination. These findings suggest that CHRNB2 may serve as a novel diagnostic biomarker and therapeutic target for CRC with peritoneal metastasis.<\/jats:p>","DOI":"10.3390\/cancers17152485","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:53:02Z","timestamp":1753696382000},"page":"2485","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cholinergic Receptor Nicotinic Beta 2 Subunit Promotes the Peritoneal Disseminating Metastasis of Colorectal Cancer"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5828-1305","authenticated-orcid":false,"given":"Shinichi","family":"Umeda","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenshiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Kishida","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-7208","authenticated-orcid":false,"given":"Norifumi","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyoshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Takami","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-2303","authenticated-orcid":false,"given":"Masamichi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuro","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative Treatment of Locally Advanced Rectal Cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1200\/JCO.2010.33.6297","article-title":"Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer","volume":"29","author":"Haller","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejca.2020.11.007","article-title":"Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II\/III colon cancer (CCOG-1302 study)","volume":"144","author":"Nakayama","year":"2021","journal-title":"Eur. J. Cancer."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Swedish Rectal Cancer Trial, Cedermark, B., Dahlberg, M., Glimelius, B., P\u00e5hlman, L., Rutqvist, L.E., and Wilking, N. (1997). Improved survival with preoperative radiotherapy in resectable rectal cancer. N. Engl. J. Med., 336, 980\u2013987.","DOI":"10.1056\/NEJM199704033361402"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/bjs.6682","article-title":"Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer","volume":"96","author":"Watanabe","year":"2009","journal-title":"Br. J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00535-015-1122-8","article-title":"Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis","volume":"51","author":"Sato","year":"2016","journal-title":"J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00384-023-04407-8","article-title":"Effect of adjuvant chemotherapy after curative resection of colorectal cancer peritoneal metastasis","volume":"38","author":"Noda","year":"2023","journal-title":"Int. J. Color. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Malka","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Elias","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41416-022-01905-4","article-title":"New insights into the unique nature of colorectal cancer peritoneal metastases-rethinking HIPEC","volume":"127","author":"Ramsay","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12957-022-02666-3","article-title":"Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: A systematic review and meta-analysis","volume":"20","author":"Li","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tonello, M., Cenzi, C., Pizzolato, E., Fiscon, R., Del Bianco, P., Pilati, P., and Sommariva, A. (2024). Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16061182"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1102\/1470-7330.2011.0016","article-title":"CT, MRI and PET imaging in peritoneal malignancy","volume":"11","author":"Patel","year":"2011","journal-title":"Cancer Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1038\/s41388-021-01945-9","article-title":"Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells","volume":"40","author":"Kanda","year":"2021","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1196\/annals.1254.007","article-title":"Nicotinic acetylcholine receptors of muscles and nerves: Comparison of their structures, functional roles, and vulnerability to pathology","volume":"998","author":"Lindstrom","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_17","first-page":"e35845","article-title":"Familial Epilepsy Associated With Concurrent CHRNB2 Mutation and RBFOX1 Exon Deletion: A Case Report","volume":"15","author":"Xu","year":"2023","journal-title":"Cureus"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0074-7742(09)00409-7","article-title":"Alzheimer\u2019s disease genetics current status and future perspectives","volume":"84","author":"Bertram","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ajmg.b.30464","article-title":"Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine","volume":"144B","author":"Ehringer","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1158\/1055-9965.EPI-09-0166","article-title":"Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch","volume":"18","author":"Perkins","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12935-022-02768-8","article-title":"CHRNB2 represses pancreatic cancer migration and invasion via inhibiting beta-catenin pathway","volume":"22","author":"Qin","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/ijc.32705","article-title":"Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer","volume":"146","author":"Umeda","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10585-021-10130-x","article-title":"The gastrointestinal microbiota in colorectal cancer cell migration and invasion","volume":"38","author":"Henstra","year":"2021","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_24","first-page":"104","article-title":"Portrait of the PI3K\/AKT pathway in colorectal cancer","volume":"1855","author":"Danielsen","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103337","DOI":"10.1016\/j.critrevonc.2021.103337","article-title":"The relationship between \u03b2-catenin and patient survival in colorectal cancer systematic review and meta-analysis","volume":"163","author":"Matly","year":"2021","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jso.26520","article-title":"Peritoneal cytology as an indicator of peritoneal metastases in colorectal cancer","volume":"124","author":"Sugarbaker","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ejso.2019.10.035","article-title":"Colorectal cancer peritoneal metastases: Biology, treatment and next steps","volume":"46","author":"Baaten","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cjp2.207","article-title":"Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid","volume":"7","author":"Rovers","year":"2021","journal-title":"J. Pathol. Clin. Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/15\/2485\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:13Z","timestamp":1760033833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/15\/2485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":28,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["cancers17152485"],"URL":"https:\/\/doi.org\/10.3390\/cancers17152485","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}